Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Leukemia, Myeloid, Acute 124Myelodysplastic Syndromes 119Precursor Cell Lymphoblastic Leukemia-Lymphoma 106Leukemia 85Hodgkin Disease 80Leukemia, Lymphocytic, Chronic, B-Cell 77Lymphoma 75Multiple Myeloma 74Lymphoma, Non-Hodgkin 74Myeloproliferative Disorders 57Graft vs Host Disease 55Lymphoma, Follicular 53Lymphoma, Mantle-Cell 49Lymphoma, Large B-Cell, Diffuse 49Leukemia, Myeloid, Accelerated Phase 49Leukemia, Myelomonocytic, Chronic 48Leukemia, Myelogenous, Chronic, BCR-ABL Positive 47Congenital Abnormalities 47Hematologic Neoplasms 45Leukemia, Myeloid, Chronic-Phase 44Lymphoma, B-Cell, Marginal Zone 43Primary Myelofibrosis 41Burkitt Lymphoma 41Blast Crisis 38Neoplasms, Plasma Cell 37Lymphoma, Large-Cell, Immunoblastic 33Waldenstrom Macroglobulinemia 25Myelodysplastic-Myeloproliferative Diseases 25Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 25Anemia, Refractory, with Excess of Blasts 24

Interventions

Exercise 5Exercise Therapy 3Manual Lymphatic Drainage 2Low-Level Light Therapy 2Indocyanine Green 2Gloves, Protective 2Compression Bandages 2tapasin 1carbohydrate-deficient transferrin 1Triamcinolone 1Tacrolimus 1Surgical Procedures, Operative 1Resistance Training 1Rehabilitation 1Physical Therapy Modalities 1Ointments 1Myofascial Release Therapy 1Muscle Stretching Exercises 1Methods 1House Calls 1Fluid Therapy 1Bupivacaine 1Athletic Tape 1Acupuncture Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Breast Cancer Lymphedema × Tacrolimus × Clear all
NCT04541290 2022-02-09

Tacrolimus as Treatment of Breast Cancer-Related Lymphedema

Odense University Hospital

Phase 1/2 Completed
20 enrolled
Breast

Breast Cancer Lymphedema

Data powered by HemOnc (CC BY 4.0) Colophon âš¡